Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells

被引:27
|
作者
Kandasamy, Matheswaran [1 ]
Bay, Boon-Huat [2 ]
Lee, Yuan-Kun [3 ]
Mahendran, Ratha [1 ]
机构
[1] Natl Univ Singapore, Dept Surg, Yong Loo Lin Sch Med, Singapore 119228, Singapore
[2] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 119228, Singapore
[3] Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 119228, Singapore
关键词
IL-15; PSA; CTL; Neutrophils; DC; Lactobacillus; BACILLUS-CALMETTE-GUERIN; HIGH-AFFINITY; UP-REGULATION; RHAMNOSUS-GG; GROWTH; IL-15; PROLIFERATION; PHAGOCYTOSIS; IL-15R-ALPHA; EXPRESSION;
D O I
10.1016/j.cellimm.2011.06.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lactobacillus rhamnosus GG (LGG) has been used to successfully induce tumor regression in an orthotopic model of bladder cancer. Increased infiltration of neutrophils and macrophages into the tumor mass was observed after therapy. This study evaluates the potential of LGG to induce a directed anti-tumor response. Lactobacilli were modified to secrete the prostate specific antigen (PSA) or IL15 and PSA (IL-15-PSA). Neutrophils and DC were exposed to LGG for 2 h as in clinical therapy for bladder cancer. Recombinant LGG activated neutrophils (elevated MHC class I expression) induced DC maturation (increased expression of CD86, CD80, CD40, MHC II and CD83), T cell proliferation and PSA specific cytotoxic T lymphocytes (CTL) activity. IL15 enhanced direct DC activation of CTL. Thus LGG secreting tumor antigens may activate antigen specific immune responses when instilled intravesically and IL15 could enhance this response. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条
  • [41] Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naive human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells
    Tomita, Yuji
    Watanabe, Eri
    Shimizu, Masumi
    Negishi, Yasuyuki
    Kondo, Yukihiro
    Takahashi, Hidemi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (10) : 1605 - 1619
  • [42] Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells
    Liu, Xinli
    Li, Jijia
    Liu, Yu
    Ding, Jianqiao
    Tong, Zhuang
    Liu, Yang
    Zhou, Yang
    Liu, Yongyu
    CELLULAR IMMUNOLOGY, 2016, 300 : 46 - 53
  • [43] In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer
    Lee, Hyun Ju
    Hong, Cheol Yi
    Kim, Mi-Hyun
    Lee, Youn-Kyung
    Thanh-Nhan Nguyen-Pham
    Park, Byoung Chul
    Yang, Deok-Hwan
    Chung, Ik-Joo
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (01): : 60 - 67
  • [44] HUMAN RECOMBINANT IL-4 DECREASES THE EMERGENCE OF NONSPECIFIC CYTOLYTIC CELLS AND FAVORS THE APPEARANCE OF MEMORY CELLS (CD4(+)CD45RO(+)) IN THE IL-2-DRIVEN DEVELOPMENT OF CYTOTOXIC T-LYMPHOCYTES AGAINST AUTOLOGOUS OVARIAN TUMOR-CELLS
    ROTH, AD
    DUPUIS, S
    ALBERTO, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 101 (02): : 362 - 368
  • [45] Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro
    Chen, Jiang
    Guo, Xiao-Zhong
    Li, Hong-Yu
    Zhao, Jia-Jun
    Xu, Wen-Da
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (05) : 817 - 829
  • [46] Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro
    Correale, P.
    Botta, C.
    Cusi, M. G.
    Del Vecchio, M. T.
    De Santi, M. M.
    Savellini, G. Gori
    Bestoso, E.
    Apollinari, S.
    Mannucci, S.
    Marra, M.
    Abbruzzese, A.
    Aquino, A.
    Turriziani, M.
    Bonmassar, L.
    Caraglia, M.
    Tagliaferri, P.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) : 1577 - 1589
  • [47] A Nanobody Against Cytotoxic T-Lymphocyte Associated Antigen-4 Increases the Anti-Tumor Effects of Specific CD8+ T Cells
    Tang, Zhuoran
    Mo, Fengzhen
    Liu, Aiqun
    Duan, Siliang
    Yang, Xiaomei
    Liang, Liu
    Hou, Xiaoqiong
    Yin, Shihua
    Jiang, Xiaobing
    Vasylieva, Natalia
    Dong, Jiexian
    Barnych, Bogdan
    Hammock, Bruce D.
    Lu, Xiaoling
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2019, 15 (11) : 2229 - 2239
  • [48] Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes
    Fang, Chih-Hao
    Cheng, Wen-Fang
    Cheng, Ya-Fang
    Lan, Keng-Li
    Lee, Jan-Mou
    BMC CANCER, 2024, 24 (01)
  • [49] Enhanced anti-tumor efficacy of "IL-15 and CCL19" -secreting CAR-T cells in human glioblastoma orthotopic xenograft model
    Chen, Wanqiong
    Hong, Limian
    Lin, Shaomei
    Xian, Na
    Yan, Cailing
    Zhao, Ningning
    Xiao, Yonglei
    Liao, Wanting
    Huang, Yuxiang
    Chen, Mingzhu
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [50] Antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes enhances the killing effect of cytotoxic T lymphocytes on tumor stem-like cells derived from cisplatin-resistant lung cancer cells
    Zhang, Xueyan
    Zhang, Yanwei
    Xu, Jianlin
    Wang, Huimin
    Zheng, Xiaoxuan
    Lou, Yuqing
    Han, Baohui
    JOURNAL OF CANCER, 2018, 9 (02): : 367 - 374